Condition 1: Anxiety. Condition 2: Depression. Anxiety disorder due to known physiological condition Neonatal cerebral depression
Conditions
Interventions
Intervention 1: Intervention group: The inclusion criteria include adolescents aged 12 to 18 years who have symptoms of anxiety and depression in the screening stage based on the DASS-21 cutoff score.
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
Female
Age
12 Years to 18 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria include adolescents aged 12 to 18 years who have symptoms of anxiety and depression in the screening stage based on the DASS-21 cutoff score. To participate in the study, participants must agree to the terms of the study (for example, audio recording of sessions, attendance at pre- and post-treatment assessment sessions)
Exclusion criteria
Exclusion criteria: Simultaneous psychological treatment Current use of psychiatric medication Risk of suicide Risk of harming others Substance abuse Psychosis and organic brain syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression and Anxiety score in Depression, Anxiety and Stress Symptoms Questionnaire (DASS-21). Timepoint: Once before the start of the study, the second stage two months after the start of the study, the third stage 4 months after the start of the study (that is, at the end of the intervention) and the fourth stage 2 months after the end of the intervention will be done for follow-up. Method of measurement: Depression, Anxiety and Stress Symptoms Questionnaire (DASS-21) This questionnaire consists of 21 statements related to the symptoms of negative emotions of depression, anxiety and stress (Akbari et al. 2006). This questionnaire was first introduced by Loybond in 1995. This questionnaire is a suitable tool for comprehensive research and screening. So far, this questionnaire has been investigated in different studies and in different age and cultural populations. For example, in the Haqs study in 2007, the reliability of this questionnaire in measuring psychological characteristics was investigated on 1400 patients with mood disorders. The results of their study reported the internal agreement between the scores of the questionnaire and the level of individual disorders. The depression subscale includes statements that measure unhappy mood, lack of self-confidence, hopelessness, worthlessness of life, lack of interest in conflict in affairs, lack of enjoyment of life and lack of energy and strength. The anxiety subscale has expressions that try to evaluate physiological hyperarousal, fears and situational anxiety, and the stress subscale includes expressions such as difficulty in achieving relaxation, nervous tension, irritability and restlessness. This questionnaire has already been used and validated in several studies in medical sciences. Among these studies, we can mention the efforts of Dr. Sahibi and his colleagues (2004), who confirmed its validity in the Iranian population and pointed out that this tool meets the necessary conditions for use in psycholo | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFaezeh Kaviyani
Islamic Azad University
Outcome results
None listed